NTRA Insider Trading

Company officers and directors buying and selling their own stock, as reported to the SEC on Form 4.

112 open-market transactions — 0 purchases, 112 sales · 2026-07-27 to 2026-10-01

Date Ticker Insider Action Shares Price Filing
2026-10-01 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.8K 415.07 SEC
2026-10-01 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 1.3K 413.31 SEC
2026-10-01 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 954 413.11 SEC
2026-10-01 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 200 411.62 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 2.8K 387.74 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 2.7K 387.65 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 2.3K 389.69 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 2.3K 386.64 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 2.2K 386.71 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 1.9K 389.71 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 1.3K 388.76 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 1.3K 388.71 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 400 385.10 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 390 385.29 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 220 390.53 SEC
2026-09-23 NTRA Sheena Jonathan — Director Sell 110 390.42 SEC
2026-09-16 NTRA Sheena Jonathan — Director Sell 1.4K 353.83 SEC
2026-09-16 NTRA Sheena Jonathan — Director Sell 800 355.95 SEC
2026-09-16 NTRA Sheena Jonathan — Director Sell 450 354.91 SEC
2026-09-16 NTRA Sheena Jonathan — Director Sell 200 356.87 SEC
2026-09-16 NTRA Sheena Jonathan — Director Sell 200 348.03 SEC
2026-09-16 NTRA Sheena Jonathan — Director Sell 100 349.05 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 14.5K 350.81 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 8.1K 348.65 SEC
2026-09-15 NTRA Sheena Jonathan — Director Sell 6.0K 350.07 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 5.8K 344.49 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 4.2K 349.51 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.7K 347.81 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.7K 345.38 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.5K 340.25 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.2K 343.56 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.0K 350.01 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.0K 342.18 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.8K 341.41 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.5K 339.24 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.1K 346.68 SEC
2026-09-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 800 351.25 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 8.5K 336.27 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 6.2K 330.05 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 6.0K 329.12 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 4.1K 342.51 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 3.8K 335.18 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 3.5K 330.98 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.8K 334.24 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.7K 341.35 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.2K 333.07 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.2K 337.17 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.1K 339.37 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.0K 340.31 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.5K 328.09 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.4K 338.30 SEC
2026-09-14 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.0K 332.02 SEC
2026-09-11 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 17.9K 327.97 SEC
2026-09-11 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 15.8K 328.95 SEC
2026-09-11 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 10.6K 327.14 SEC
2026-09-11 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 3.6K 326.11 SEC
2026-09-11 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.3K 329.62 SEC
2026-09-11 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 800 325.01 SEC
2026-09-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 15.2K 326.89 SEC
2026-09-01 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 1.7K 320.99 SEC
2026-09-01 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.4K 320.92 SEC
2026-09-01 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.0K 319.76 SEC
2026-09-01 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 600 321.91 SEC
2026-08-10 NTRA Fesko John — PRESIDENT, CHIEF BUS. OFFICER Sell 6.5K 321.53 SEC
2026-08-10 NTRA Sheena Jonathan — Director Sell 6.0K 325.32 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 5.1K 316.61 SEC
2026-08-07 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 2.0K 320.90 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 900 313.07 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 850 314.25 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 600 315.32 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 489 320.90 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 400 311.88 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 400 310.23 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 200 317.97 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 100 318.63 SEC
2026-08-07 NTRA Sheena Jonathan — Director Sell 100 308.40 SEC
2026-08-04 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 478 274.22 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.2K 267.79 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 1.2K 267.99 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 947 263.94 SEC
2026-08-03 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 731 267.99 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 676 263.86 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 612 268.22 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 410 267.99 SEC
2026-08-03 NTRA RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER Sell 334 267.99 SEC
2026-08-03 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 317 267.99 SEC
2026-08-03 NTRA Fesko John — PRESIDENT, CHIEF BUS. OFFICER Sell 295 267.99 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 296 267.08 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 300 259.98 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 200 261.49 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 192 265.28 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 160 259.98 SEC
2026-08-03 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 128 268.70 SEC
2026-08-03 NTRA Sheena Jonathan — Director Sell 109 267.99 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 80 265.27 SEC
2026-08-03 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 70 261.03 SEC
2026-07-29 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 1.9K 249.38 SEC
2026-07-28 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 3.6K 254.07 SEC
2026-07-28 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 1.2K 254.07 SEC
2026-07-28 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.2K 254.07 SEC

What Form 4 actually tells you

Officers, directors and anyone holding more than 10% of a company must report trades in its stock to the SEC within two business days, on Form 4. The filings are public the moment they land, and every row above links to the original.

Buys and sells are not symmetric

This is the thing worth internalising. An insider sells for a hundred reasons that say nothing about the company — diversification, a house, a tax bill, or a pre-scheduled 10b5-1 plan set up months earlier. An insider buying on the open market with their own money has exactly one obvious motive.

Which is why this page shows only open-market purchases and sales. Form 4 also reports option grants, option exercises and shares withheld to cover taxes; those are compensation mechanics, and screens that fold them in produce noise that looks like signal.

Why cluster buying is the part worth watching

A single insider buying tells you very little. They may be topping up after a sale, converting a bonus, or simply buying because they always buy in January. The signal researchers actually find informative is a cluster: several different insiders at the same company, buying on the open market, independently, inside a short window.

That is hard to explain away as personal circumstance. It usually means several people with the same non-public view of the business reached the same conclusion at once. The table above lists companies where three or more distinct insiders bought within 90 days — and it is worth noting how short that list usually is. Genuine clusters are rare, which is rather the point.

Timing and limits

Where this comes from

Parsed directly from SEC EDGAR — the daily filing index, then each Form 4's XML. Public domain, no vendor in between, which is why the original filing can be linked from every row.